NEW YORK (Reuters Health) – Long-term glucocorticoid (GC) users see greater gains in spine bone-mineral density when treated with the monoclonal antibody denosumab versus oral alendronate, a small clinical trial shows. The drug also proved superior at lowering bone-turnover markers at 12 months, researchers in Hong Kong report in Bone. “Denosumab may be considered as
A company-initiated recall of two models of EMBLEM S-ICD (Boston Scientific) subcutaneous implantable cardioverter defibrillator pulse generators has been categorized as Class I by the US Food and Drug Administration (FDA), the agency announced today. The FDA notes that the advisory, which was communicated to patients and doctors in December, applies to 2825 of the
Single and multiple hip, vertebral, and rib fractures strongly affect the quality of life of older adults over a prolonged period of time, according to a new study published in the Journal of Bone and Mineral Research. For the study, which involved 10-year follow-up data, researchers determined the long-term impact of fragility fractures on health-related
(HealthDay)—Deep learning methods allow senior medical specialists to deliver their expertise to emergency medicine clinicians via use of a deep neural network, which is associated with considerable improvement in sensitivity and specificity of detecting fractures in wrist radiographs, according to a study published online Oct. 22 in the Proceedings of the National Academy of Sciences.
Older women who suffer vertebral fractures rarely attract the attention of health care providers. A dissertation at Sahlgrenska Academy, Sweden, throws new light on a group of individuals with chronic pain as a constant companion. “We must become more aware of these women and take their experiences of pain seriously,” says Hilda Svensson, district nurse
Certain medications commonly used to treat heartburn, acid reflux, and ulcers are linked with higher bone fracture risks among patients on dialysis, according to a new study. Almost three-quarters of patients who had a hip fracture had used the medications in the 3 years preceding their event. The findings appear in an upcoming issue of
Patients who take osteoporosis drugs for long periods typically are advised to temporarily discontinue the drugs to prevent rare but serious side effects to the jaw and thighs. A Loyola Medicine study has found that 15.4 percent of patients who take so-called “drug holidays” from osteoporosis drugs called bisphosphonates experienced bone fractures. During a six-year
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok